SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending after shares surged to record highs, briefly crossing the $1 trillion market-capitalization mark for the first time amid a broad semiconductor rally that also lifted Arm and Intel on AI-driven demand. Community reaction is split between bulls celebrating the milestone and skeptics calling the move an overextended bubble, with debate over taking profits versus holding amid elevated valuation concerns.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is surging alongside other chip names on expectations that agentic AI workloadsdriven by rapid adoption of Meta's Muse AI agentwill sharply lift CPU demand, amplified by reported comments from Intel's CEO that it can currently meet only about half of customer CPU demand. The community is split between bulls touting heavy call-option buying, short covering, and a broader chip-sector rally, and skeptics calling the move overdone and the stock overvalued relative to peers.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Shares are surging after the U.S. reached a security agreement with Denmark and Greenland granting Washington permanent military rights on the island, a deal traders see as de-risking and potentially accelerating Critical Metals' Tanbreez rare-earth project. Community sentiment is heavily bullish with widespread short-squeeze speculation around elevated short interest, though skeptics counter that the pre-revenue company is years from processing capacity and expect the move to fade.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is sliding after its Capital Markets Day, where management guided to mid-single-digit revenue growth through 2030 and laid out long-term blockbuster pipeline targets that failed to ease concerns over Eli Lilly competition and looming semaglutide patent expirations. Traders are split, with dip-buyers calling the stock oversold on valuation while bears criticize CEO Mike Doustdar's credibility, the cautious growth outlook, and pipeline depth.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X ETF

A broad semiconductor rally  with the chip index breaking out above key technical resistance and memory names leading gains despite hawkish Fed/rate-hike expectations, an oil spike, and lingering AI-bubble fears  is crushing the 3x inverse fund for a steep double-digit slide. Traders are split between aggressively averaging down and cutting losses, with skeptics warning of leveraged-ETF decay and characterizing the chip strength as manipulation or a bull trap.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is rallying on reports that it is in advanced settlement talks with California's attorney general over the state-led antitrust suit blocking its Warner Bros. Discovery merger, with reported terms including a large California production pledge, annual film-release commitments, and CNN editorial safeguards. Traders are largely bullish that a settlement would clear the deal's last major obstacle ahead of a per-day delay fee tied to the merger agreement, though some caution that no official agreement has been announced and debate persists over whether the reported concessions amount to regulatory overreach.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET shares are rallying as traders await the September commercial and production updates management promised with Q2 earnings, with ECOC week supplying a catalyst in the form of an industry award for the company's hybrid photonic integration platform and a 3.2T optics demonstration from partner Lessengers that the community ties to POET's technology. Bulls cite the award, manufacturing ramp signals like heavy hiring, and anticipated customer announcements, while skeptics dismiss awards as meaningless without confirmed production shipments and revenue.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is rallying sharply amid a broader risk-on crypto rally, with traders focused on whether it can push through a heavily discussed round-number resistance level near current prices. Bulls see the volume-backed move as the start of a bigger breakout, while skeptics warn long-time holders could sell heavily into that level, which has capped previous rallies.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is rallying ahead of its upcoming fiscal Q2 earnings report, with traders anticipating a beat and guidance raise, supported by pre-earnings analyst commentary and a QNX-Sift partnership for streaming physical AI telemetry data. Discussion splits between bulls touting QNX's expanding role in physical AI and robotics along with hopes for an Alloy Kore design-win update, and skeptics shorting the rally while citing executive share sales and dilution.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

A sharp tech-led rally toward record territory is dominating discussion, with traders attributing the move to sliding oil prices and hopes of U.S.-Iran diplomatic progress that have overshadowed the Fed's recent rate hike; bulls are piling into calls amid short-squeeze euphoria, while skeptics call the move an overextended, manipulated pump at risk of reversing.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Is MIRA Pharmaceuticals Stock Gaining Tuesday?

MIRA Pharmaceuticals (NASDAQ: MIRA) stock jumps as MIRA-55 meets key preclinical study milestones for non-opioid inflammatory pain relief.read more...

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

Others

What's Going On With MIRA Pharma Stock Tuesday?

MIRA Pharmaceuticals (NASDAQ: MIRA) eyes IND submission for Mira-55 after new 2026 data confirms no CNS side effects.read more...

Short Interest in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Drops By 13.9%

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA - Get Free Report) saw a significant decrease in short interest in February. As of February 27th, there was short interest totaling 489,206 shares, a decrease...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Up 29.4% in February

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA - Get Free Report) was the target of a significant increase in short interest in the month of February. As of February 13th, there was short interest totaling...

MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Down 6.6% - Time to Sell?

MIRA Pharmaceuticals (NASDAQ:MIRA) Trading Down 6.6% - Time to Sell...

MIRA Pharmaceuticals (NASDAQ:MIRA) Stock Price Down 6.6% - Time to Sell?

MIRA Pharmaceuticals (NASDAQ:MIRA) Stock Price Down 6.6% - What's Next...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Sees Significant Growth in Short Interest

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA - Get Free Report) was the recipient of a large increase in short interest in the month of December. As of December 31st, there was short interest totaling...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Update

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA - Get Free Report) was the target of a large decrease in short interest in the month of December. As of December 15th, there was short interest totaling...

MIRA Pharmaceuticals (NASDAQ:MIRA) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen downgraded shares of MIRA Pharmaceuticals from a "hold" rating to a "sell" rating in a research note on Saturday...

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. It engages in developing its product candidates, Ketamir-2 and MIRA-55, designed to address unmet medical needs in pain management, depression, PTSD, and cognitive function. The company was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.

Mira Pharmaceuticals Inc

Mira Pharmaceuticals Stock Soars 70% After-Hours As Pain Drug Outperforms Morphine; Retail Sees ‘Blockbuster Drug’ In The Making

Equity

Neutral Sentiment

Rising interest rates

Surging bond yields

Oil/energy volatility

Trump/political risk

U.S. investors are navigating a stacked macro backdrop, with the Federal Reserve hiking rates for the first time since July 2023, the 10-year Treasury yield hitting 5.00% - its highest level since 2007 - and oil prices swinging between $94 and $105 a barrel amid the ongoing U.S.-Iran conflict and Saudi pipeline disruptions. What's the biggest risk to your portfolio right now? Vote and explain your reasoning in the comments.

With the Fed hiking rates for the first time since 2023, the 10-year Treasury yield near 5%, and oil prices swinging on the U.S.-Iran conflict, what&#39;s the biggest risk to your portfolio right now?

Stocktwits

With the Fed hiking rates for the first time since 2023, the 10-year Treasury yield near 5%, and oil prices swinging on the U.S.-Iran conflict, what's the biggest risk to your portfolio right now?

Feed

News

Sentiment

Fundamentals

Info

MIRA Mira Pharmaceuticals Inc

Fundamentals

Latest MIRA News